AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : Breast Cancer Research
Abstract Background The overexpression of human epidermal growth factor receptor-2 (HER2) in breast cancer is a...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name : BMC Cancer
We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...
Posted by : Mme. Aurélia MEURISSE,
Journal name : Breast
AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : European Journal of Cancer
Since the MOSAIC study, oxaliplatin-based adjuvant chemotherapy has been the standard treatment of stage III colon...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : Annals of Oncology
Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...
Posted by : , Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : JNCI J Natl Cancer Inst
AbstractTraditionally, the efficacy of cancer treatment in patients with advance or metastatic disease in clinical...
Posted by : Pr. Franck BONNETAIN
Journal name : Annals of Oncology
ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...
Posted by : Pr. Franck BONNETAIN
Journal name : Expert Review of Anticancer Therapy
Background:To assess the efficacy of a patient educational program built according to guidelines that aims at reducing...
Posted by : Pr. Franck BONNETAIN
Journal name : British Journal of Cancer
Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...
Posted by : Mme. Aurélia MEURISSE, Pr. Franck BONNETAIN
Journal name : Lancet Gastroenterology Hepatology
BackgroundEven if a large majority of out-of-hospital cardiac arrest (OHCA) survivors appear to have a good neurological...
Posted by : Pr. Franck BONNETAIN
Journal name : Resuscitation
The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...
Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH,
Journal name : La revue de l'infirmière
SummaryData in the literature regarding the care pathway of pancreatic cancer patients are limited. The objective of the...
Posted by : Pr. Franck BONNETAIN
Journal name : Bulletin du Cancer
Background: Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of...
Posted by : , Pr. Franck BONNETAIN
Journal name : Trials
AbstractBackground:Frailty is highly prevalent in elderly people. While significant progress has been made to...
Posted by : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Journal name : BMC Geriatrics
AbstractBackground:Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : BMC Cancer
Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...
Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY
Journal name : Cancer Medecine
Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer...
Posted by : Pr. Franck BONNETAIN
Journal name : Lancet Oncology
AbstractTemozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs)....
Posted by : Dr. Dewi VERNEREY
Journal name : Endocrine-Related Cancer
AbstractThe diagnosis system for allograft loss lacks accurate individual risk stratification on the basis of...
Posted by : Dr. Dewi VERNEREY
Journal name : J Am Soc Nephrol